Table 5 Patient characteristics per subgroup
Patient characteristics. | |||
|---|---|---|---|
requested SO group | Control group | p | |
Included patients | 188 (100%) | 178 (100%) | |
Sex | |||
Males | 102 (54.3%) | 82 (46.1%) | 0.117 |
Females | 86 (45.7%) | 96 (53.9%) | |
Age (years) | |||
Mean | 57.9 | 59.6 | |
Median | 62 | 61 | 0.359 |
Range | [15-86] | [18-92] | |
Types of tumor | |||
Soft tissue | 117 (62.2%) | 98 (55.1%) | |
Bone tissue | 13 (6.9%) | 8 (4.5%) | 0.128 |
Visceral tissue | 58 (30.9%) | 72 (40.4%) | |
Localization | |||
Upper limb | 15 (8.%) | 19 (10.7%) | |
Lower limb | 45 (23.9%) | 31 (17.4%) | |
Abdomen | 44 (23.4%) | 57 (32%) | |
Thorax | 31 (16.5%) | 23 (12.9%) | 0.313 |
Head and Neck | 16 (8.5%) | 13 (7.3%) | |
Pelvis | 25 (13.3%) | 20 (11.2%) | |
Retroperitoneum | 10 (5.3%) | 11 (6.2%) | |
Axial skeleton | 1 (0.5%) | 0 (0%) | |
Multiple localizations | 1 (0.5%) | 4 (2.2%) | |
Grade | |||
Grade I | 47 (25%) | 38 (21.3%) | |
Grade II | 36 (19.1%) | 41 (23%) | |
Grade III | 50 (26.6%) | 47 (26.4%) | 0.716 |
Non applicable | 52 (27.2%) | 51 (28.7%) | |
Unknown | 3 (1.6%) | 1 (0.6%) | |
Histological subtypes | |||
Liposarcoma | 37 (19.7%) | 19 (10.7%) | |
NOS Sarcoma | 32 (17.0%) | 20 (11.2%) | |
GIST | 23 (12.2%) | 42 (23.6%) | |
Myxofibrosarcoma | 9 (4.8%) | 3 (1.7%) | |
Leiomyosarcoma | 7 (3.7%) | 19 (10.7%) | |
PNET/Ewing | 6 (3.2%) | 2 (1.1%) | |
Rhabdomyosarcoma | 6 (3.2%) | 2 (1.1%) | < 0.001. |
Chondrosarcoma | 6 (3.2%) | 3 (1.7%) | |
Dermatofibrosarcoma | 4 (2.1%) | 16 (9.0%) | |
protuberans | |||
Uterine Leiomyosarcoma | 5 (2.7%) | 7 (3.9%) | |
Osteosarcoma | 5 (2.7%) | 6 (3.4%) | |
Kaposi Sarcoma | 5 (2.7%) | 13 (7.3%) | |
Synovialosarcoma | 5 (2.7%) | 2 (1.1%) | |
Angiosarcoma | 3 (1.6%) | 7 (3.9%) | |
Unclassified malignant tumor | 7 (3.7%) | 7 (3.9%) | |
Other | 28 (14.9%) | 10 (5.6%) | |